Literature DB >> 34607912

Neurosarcoidosis: Pathophysiology, Diagnosis, and Treatment.

Michael J Bradshaw1, Siddharama Pawate2, Laura L Koth2, Tracey A Cho2, Jeffrey M Gelfand2.   

Abstract

Although often regarded as a protean illness with myriad clinical and imaging manifestations, neurosarcoidosis typically presents as recognizable syndromes that can be approached in a rational, systematic fashion. Understanding of neurosarcoidosis has progressed significantly in recent years, including updated diagnostic criteria and advances in treatment. The diagnosis of neurosarcoidosis is established by the clinical syndrome, imaging and histopathological findings, and exclusion of other causes. Mounting evidence supports the use of tumor necrosis factor inhibitors as an important addition to the therapeutic armamentarium, along with glucocorticoids and steroid-sparing cytotoxic immunosuppressants. In this narrative review, we summarize recent advances in the diagnosis and treatment of neurosarcoidosis.
Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.

Entities:  

Mesh:

Year:  2021        PMID: 34607912      PMCID: PMC8495503          DOI: 10.1212/NXI.0000000000001084

Source DB:  PubMed          Journal:  Neurol Neuroimmunol Neuroinflamm        ISSN: 2332-7812


  59 in total

1.  Epidemiology of Sarcoidosis 1946-2013: A Population-Based Study.

Authors:  Patompong Ungprasert; Eva M Carmona; James P Utz; Jay H Ryu; Cynthia S Crowson; Eric L Matteson
Journal:  Mayo Clin Proc       Date:  2015-12-22       Impact factor: 7.616

2.  Sarcoidosis blood transcriptome reflects lung inflammation and overlaps with tuberculosis.

Authors:  Laura L Koth; Owen D Solberg; Jeffrey C Peng; Nirav R Bhakta; Christine P Nguyen; Prescott G Woodruff
Journal:  Am J Respir Crit Care Med       Date:  2011-08-18       Impact factor: 21.405

3.  Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of neurosarcoidosis.

Authors:  Claire Bridel; Delphine S Courvoisier; Nicolas Vuilleumier; Patrice H Lalive
Journal:  J Neuroimmunol       Date:  2015-05-21       Impact factor: 3.478

4.  Actionable diagnosis of neuroleptospirosis by next-generation sequencing.

Authors:  Michael R Wilson; Samia N Naccache; Erik Samayoa; Mark Biagtan; Hiba Bashir; Guixia Yu; Shahriar M Salamat; Sneha Somasekar; Scot Federman; Steve Miller; Robert Sokolic; Elizabeth Garabedian; Fabio Candotti; Rebecca H Buckley; Kurt D Reed; Teresa L Meyer; Christine M Seroogy; Renee Galloway; Sheryl L Henderson; James E Gern; Joseph L DeRisi; Charles Y Chiu
Journal:  N Engl J Med       Date:  2014-06-04       Impact factor: 91.245

Review 5.  Hypothalamic-pituitary sarcoidosis with vision loss and hypopituitarism: case series and literature review.

Authors:  Jeremy Anthony; Gregory J Esper; Adriana Ioachimescu
Journal:  Pituitary       Date:  2016-02       Impact factor: 4.107

Review 6.  Recent advances in endobronchial ultrasound-guided transbronchial needle aspiration.

Authors:  Takahiro Nakajima; Kazuhiro Yasufuku; Taiki Fujiwara; Ichiro Yoshino
Journal:  Respir Investig       Date:  2016-03-05

7.  Discriminating long myelitis of neuromyelitis optica from sarcoidosis.

Authors:  Eoin P Flanagan; Timothy J Kaufmann; Karl N Krecke; Allen J Aksamit; Sean J Pittock; B Mark Keegan; Caterina Giannini; Brian G Weinshenker
Journal:  Ann Neurol       Date:  2016-02-12       Impact factor: 10.422

8.  Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series.

Authors:  Jeffrey M Gelfand; Michael J Bradshaw; Barney J Stern; David B Clifford; Yunxia Wang; Tracey A Cho; Laura L Koth; Stephen L Hauser; Jason Dierkhising; NgocHanh Vu; Subramaniam Sriram; Harold Moses; Francesca Bagnato; Jeffrey A Kaufmann; Deidre J Ammah; Tsion H Yohannes; Mark J Hamblin; Nagagopal Venna; Ari J Green; Siddharama Pawate
Journal:  Neurology       Date:  2017-10-13       Impact factor: 9.910

9.  Pleocytosis is not fully responsible for low CSF glucose in meningitis.

Authors:  Maxime O Baud; Jeffrey R Vitt; Nathaniel M Robbins; Rafael Wabl; Michael R Wilson; Felicia C Chow; Jeffrey M Gelfand; S Andrew Josephson; Steve Miller
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-12-22

10.  Clinical and MRI phenotypes of sarcoidosis-associated myelopathy.

Authors:  Olwen C Murphy; Andrea Salazar-Camelo; Jorge A Jimenez; Paula Barreras; Maria I Reyes; Maria A Garcia; David R Moller; Edward S Chen; Carlos A Pardo
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-04-08
View more
  5 in total

1.  The CSF in neurosarcoidosis contains consistent clonal expansion of CD8 T cells, but not CD4 T cells.

Authors:  Michael A Paley; Brandi J Baker; S Richard Dunham; Nicole Linskey; Claudia Cantoni; Kenneth Lee; Lynn M Hassman; Jennifer Laurent; Elisha D O Roberson; David B Clifford; Wayne M Yokoyama
Journal:  J Neuroimmunol       Date:  2022-04-01       Impact factor: 3.221

2.  Relevance of Medullary Vein Sign in Neurosarcoidosis.

Authors:  Richard Liberio; Emily Kramer; Anza B Memon; Ryan Reinbeau; Parissa Feizi; Joe Joseph; Janet Wu; Shitiz Sriwastava
Journal:  Neurol Int       Date:  2022-08-14

Review 3.  Sarcoid Uveitis: An Intriguing Challenger.

Authors:  Pia Allegri; Sara Olivari; Federico Rissotto; Roberta Rissotto
Journal:  Medicina (Kaunas)       Date:  2022-07-04       Impact factor: 2.948

4.  A Rare Case of Neurosarcoidosis Overlapped with Sjogren's Syndrome.

Authors:  Wenxin Cai; Ru Li; Jing He; Miao Shao; Zhanguo Li
Journal:  J Clin Med       Date:  2022-09-27       Impact factor: 4.964

5.  Pachymeningitis in Biopsy-Proven Sarcoidosis: Clinical Course, Radiographic Findings, Response to Treatment, and Long-term Outcomes.

Authors:  Pressley A Chakales; Max C Herman; Ling Chen Chien; Spencer K Hutto
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2022-09-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.